Twin Peaks Wealth Advisors’s AngioDynamics ANGO Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33	Closed	-$375	–	336
2026 Q1	$375	Buy	+33	New	+$358	﹤0.01%	2078

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WCM

Weber Capital Management San Francisco, California $118M AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Twin Peaks Wealth Advisors's ANGO Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of AngioDynamics (ANGO) in Q2 2026, closing a stake of 33 shares — an estimated $375 sold.

Twin Peaks Wealth Advisors first reported a position in ANGO in Q1 2026 and held it in 1 quarter. The position peaked at $375 in Q1 2026. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

Twin Peaks Wealth Advisors reported no remaining AngioDynamics position as of Q2 2026 after selling out during the quarter.
Twin Peaks Wealth Advisors sold 33 AngioDynamics shares in Q2 2026, an estimated $375.
Twin Peaks Wealth Advisors first reported a position in AngioDynamics in Q1 2026 and held it in 1 quarter.
Twin Peaks Wealth Advisors's AngioDynamics position peaked at $375 in Q1 2026.
161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.